Elevated MMP Expression in the MRL Mouse Retina Creates a Permissive Environment for Retinal Regeneration

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2008 Apr 4

PMID 18385092

Citations 30

Authors

Budd Tucker

Henry Klassen

Liu Yang

Dong Feng Chen

Michael J Young

Affiliations

Soon will be listed here.

Abstract

Purpose: The MRL/MpJ (healer) mouse is an established model for autoimmune studies and was recently identified as having a profound ability to undergo scarless regeneration of the tissue in the ear and heart. This regenerative capacity has been linked to elevated matrix metalloproteinase (MMP)-2 and -9 expression, giving this mouse the ability to degrade and remove inhibitory basement membrane molecules. Although elevated MMP expression has been reported in somatic tissues in this strain, little is known about MMP expression and the response to injury in the MRL/MpJ mouse retina. The purpose of this study was to investigate whether increased MMP expression and subsequent decreased inhibitory extracellular matrix molecule deposition in the MRL/MpJ mouse retina produces a permissive regenerative environment.

Methods: Experiments were performed using 3- to 4-week-old MRL/MpJ, retinal degenerative (rd1), and C57BL/6 (wild-type) mice. Western blotting, oligo-microarray, and immunohistochemical analyses were used to determine the level and location of MMP and extracellular matrix (ECM) protein expression. Retinal responses to injury were modeled by retinal detachment in vivo and in retinal explantation in vitro. The capacity of the retinal environment to support photoreceptor cell migration, integration, or regeneration was analyzed using hematoxylin-eosin, immunohistochemical staining, and cell counting.

Results: Compared with C57BL/6J animals, MRL/MpJ mice exhibit elevated levels of MMP-2, -9, and -14 and decreased levels of the inhibitory proteins neurocan and CD44 within the retina. Although similar increases in MMP-2, -9, and CD44s (CD44 degradation product) were observed in the rd1 retina, elevated levels of the inhibitory ECM molecules (neurocan and CD44) remained. Thus, the MRL retinal environment, which expresses lower levels of inhibitory ECM molecules after injury, was more conducive to regeneration and enhanced photoreceptor integration in vitro than C57BL/6J or rd1 controls.

Conclusions: The MRL mouse retina shows elevated MMP expression and decreased levels of scar-related inhibitory molecules, which leads to a retinal environment that is more permissive for neural regeneration and cell integration after in vitro retinal explantation.

Citing Articles

Biomarkers in Ataxia-Telangiectasia: a Systematic Review.

Tiet M, Gutu B, Springall-Jeggo P, Coman D, Willemsen M, Van Os N J Neurol. 2025; 272(2):110.

PMID: 39812834 PMC: 11735505. DOI: 10.1007/s00415-024-12766-7.

Retina regeneration: lessons from vertebrates.

Sharma P, Ramachandran R Oxf Open Neurosci. 2024; 1:kvac012.

PMID: 38596712 PMC: 10913848. DOI: 10.1093/oons/kvac012.

The superior healing capacity of MRL tendons is minimally influenced by the systemic environment of the MRL mouse.

Frankewycz B, Bell R, Chatterjee M, Andarawis-Puri N Sci Rep. 2023; 13(1):17242.

PMID: 37821476 PMC: 10567747. DOI: 10.1038/s41598-023-42449-8.

Incomplete Recovery of Zebrafish Retina Following Cryoinjury.

Dzulova D, Lawless D, Pinton G, Renner N, Schorderet D Cells. 2022; 11(8).

PMID: 35456052 PMC: 9030934. DOI: 10.3390/cells11081373.

An insight on established retinal injury mechanisms and prevalent retinal stem cell activation pathways in vertebrate models.

Sherpa R, Hui S Animal Model Exp Med. 2021; 4(3):189-203.

PMID: 34557646 PMC: 8446703. DOI: 10.1002/ame2.12177.

References

Heber-Katz E, Chen P, Clark L, Zhang X, Troutman S, Blankenhorn E . Regeneration in MRL mice: further genetic loci controlling the ear hole closure trait using MRL and M.m. Castaneus mice. Wound Repair Regen. 2004; 12(3):384-92. DOI: 10.1111/j.1067-1927.2004.012308.x. View

Miyazaki K, Uchiyama K, Imokawa Y, Yoshizato K . Cloning and characterization of cDNAs for matrix metalloproteinases of regenerating newt limbs. Proc Natl Acad Sci U S A. 1996; 93(13):6819-24. PMC: 39111. DOI: 10.1073/pnas.93.13.6819. View

Inatani M, Tanihara H, Oohira A, Honjo M, Kido N, Honda Y . Upregulated expression of neurocan, a nervous tissue specific proteoglycan, in transient retinal ischemia. Invest Ophthalmol Vis Sci. 2000; 41(9):2748-54. View

Mohand-Said S, Hicks D, Simonutti M, Tran-Minh D, Dreyfus H, Silverman M . Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse. Ophthalmic Res. 1997; 29(5):290-7. DOI: 10.1159/000268027. View

Chaitin M, Ankrum M, Wortham H . Distribution of CD44 in the retina during development and the rds degeneration. Brain Res Dev Brain Res. 1996; 94(1):92-8. DOI: 10.1016/0165-3806(96)00046-6. View

Heber-Katz E . The regenerating mouse ear. Semin Cell Dev Biol. 1999; 10(4):415-9. DOI: 10.1006/scdb.1999.0328. View

Siconolfi L, Seeds N . Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush. J Neurosci Res. 2003; 74(3):430-4. DOI: 10.1002/jnr.10786. View

Zhang Y, Klassen H, Tucker B, Perez M, Young M . CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism. J Neurosci. 2007; 27(17):4499-506. PMC: 6673008. DOI: 10.1523/JNEUROSCI.0200-07.2007. View

Ponta H, Sherman L, Herrlich P . CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003; 4(1):33-45. DOI: 10.1038/nrm1004. View

10.

Heber-Katz E, Leferovich J, Bedelbaeva K, Gourevitch D, Clark L . The scarless heart and the MRL mouse. Philos Trans R Soc Lond B Biol Sci. 2004; 359(1445):785-93. PMC: 1693365. DOI: 10.1098/rstb.2004.1468. View

11.

Thomas B, Aramant R, Sadda S, Seiler M . Retinal transplantation. A treatment strategy for retinal degenerative diseases. Adv Exp Med Biol. 2007; 572:367-76. View

12.

Romanic A, White R, Arleth A, Ohlstein E, Barone F . Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke. 1998; 29(5):1020-30. DOI: 10.1161/01.str.29.5.1020. View

13.

Ferguson T, Muir D . MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci. 2000; 16(2):157-67. DOI: 10.1006/mcne.2000.0859. View

14.

Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den Oord J . Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest. 1999; 104(11):1507-15. PMC: 409857. DOI: 10.1172/JCI6886. View

15.

Nagase H, Visse R, Murphy G . Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69(3):562-73. DOI: 10.1016/j.cardiores.2005.12.002. View

16.

Yang L, Bula D, Arroyo J, Chen D . Preventing retinal detachment-associated photoreceptor cell loss in Bax-deficient mice. Invest Ophthalmol Vis Sci. 2004; 45(2):648-54. DOI: 10.1167/iovs.03-0827. View

17.

Pizzi M, Crowe M . Matrix metalloproteinases and proteoglycans in axonal regeneration. Exp Neurol. 2007; 204(2):496-511. DOI: 10.1016/j.expneurol.2006.12.012. View

18.

Strongin A, Collier I, Bannikov G, Marmer B, Grant G, Goldberg G . Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem. 1995; 270(10):5331-8. DOI: 10.1074/jbc.270.10.5331. View

19.

Busch S, Silver J . The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol. 2007; 17(1):120-7. DOI: 10.1016/j.conb.2006.09.004. View

20.

Deryugina E, Quigley J . Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006; 25(1):9-34. DOI: 10.1007/s10555-006-7886-9. View